Sharlene L Leurig
Examiner (ID: 11491)
Most Active Art Unit | 2879 |
Art Unit(s) | 2879 |
Total Applications | 146 |
Issued Applications | 124 |
Pending Applications | 2 |
Abandoned Applications | 20 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6396914
[patent_doc_number] => 20100304483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'T-CELL VACCINATION IN THE TREATMENT OF HIV INFECTION'
[patent_app_type] => utility
[patent_app_number] => 12/796971
[patent_app_country] => US
[patent_app_date] => 2010-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10379
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20100304483.pdf
[firstpage_image] =>[orig_patent_app_number] => 12796971
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/796971 | T-CELL VACCINATION IN THE TREATMENT OF HIV INFECTION | Jun 8, 2010 | Abandoned |
Array
(
[id] => 7579638
[patent_doc_number] => 20110293521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'Anti-viral compositions and methods for administration'
[patent_app_type] => utility
[patent_app_number] => 12/802145
[patent_app_country] => US
[patent_app_date] => 2010-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 32913
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20110293521.pdf
[firstpage_image] =>[orig_patent_app_number] => 12802145
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/802145 | Anti-viral compositions and methods for administration | May 27, 2010 | Abandoned |
Array
(
[id] => 6343104
[patent_doc_number] => 20100330041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'Viral-based antimicrobial agent use in ethanol production'
[patent_app_type] => utility
[patent_app_number] => 12/801180
[patent_app_country] => US
[patent_app_date] => 2010-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6600
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0330/20100330041.pdf
[firstpage_image] =>[orig_patent_app_number] => 12801180
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/801180 | Viral-based antimicrobial agent use in ethanol production | May 25, 2010 | Abandoned |
Array
(
[id] => 6262231
[patent_doc_number] => 20100297072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy'
[patent_app_type] => utility
[patent_app_number] => 12/776488
[patent_app_country] => US
[patent_app_date] => 2010-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9800
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297072.pdf
[firstpage_image] =>[orig_patent_app_number] => 12776488
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/776488 | Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy | May 9, 2010 | Abandoned |
Array
(
[id] => 6102568
[patent_doc_number] => 20110166061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'LONG LASTING FUSION PEPTIDE INHIBITORS FOR HIV INFECTION'
[patent_app_type] => utility
[patent_app_number] => 12/767646
[patent_app_country] => US
[patent_app_date] => 2010-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8285
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166061.pdf
[firstpage_image] =>[orig_patent_app_number] => 12767646
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/767646 | LONG LASTING FUSION PEPTIDE INHIBITORS FOR HIV INFECTION | Apr 25, 2010 | Abandoned |
Array
(
[id] => 7579766
[patent_doc_number] => 20110293649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus Like Particles'
[patent_app_type] => utility
[patent_app_number] => 12/728008
[patent_app_country] => US
[patent_app_date] => 2010-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 36701
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20110293649.pdf
[firstpage_image] =>[orig_patent_app_number] => 12728008
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/728008 | In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus Like Particles | Mar 18, 2010 | Abandoned |
Array
(
[id] => 6435215
[patent_doc_number] => 20100278937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'COMPOSITIONS AND METHODS TO PREVENT AND/OR TREAT CANCER WITH PA-CARD'
[patent_app_type] => utility
[patent_app_number] => 12/709806
[patent_app_country] => US
[patent_app_date] => 2010-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 23996
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0278/20100278937.pdf
[firstpage_image] =>[orig_patent_app_number] => 12709806
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/709806 | COMPOSITIONS AND METHODS TO PREVENT AND/OR TREAT CANCER WITH PA-CARD | Feb 21, 2010 | Abandoned |
Array
(
[id] => 11814921
[patent_doc_number] => 09718863
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-01
[patent_title] => 'Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/147193
[patent_app_country] => US
[patent_app_date] => 2010-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 24142
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13147193
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/147193 | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | Feb 5, 2010 | Issued |
Array
(
[id] => 6616144
[patent_doc_number] => 20100310591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'Ii-KEY HYBRID PEPTIDES THAT MODULATE THE IMMUNE RESPONSE TO INFLUENZA'
[patent_app_type] => utility
[patent_app_number] => 12/695892
[patent_app_country] => US
[patent_app_date] => 2010-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21469
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0310/20100310591.pdf
[firstpage_image] =>[orig_patent_app_number] => 12695892
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/695892 | Ii-KEY HYBRID PEPTIDES THAT MODULATE THE IMMUNE RESPONSE TO INFLUENZA | Jan 27, 2010 | Abandoned |
Array
(
[id] => 13107345
[patent_doc_number] => 10072307
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-09-11
[patent_title] => Isolation of viruses using anionic resin beads
[patent_app_type] => utility
[patent_app_number] => 12/693139
[patent_app_country] => US
[patent_app_date] => 2010-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 8520
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12693139
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/693139 | Isolation of viruses using anionic resin beads | Jan 24, 2010 | Issued |
Array
(
[id] => 4497647
[patent_doc_number] => 07947822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-24
[patent_title] => 'HIV vaccines based on Env of multiple clades of HIV'
[patent_app_type] => utility
[patent_app_number] => 12/683844
[patent_app_country] => US
[patent_app_date] => 2010-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 109
[patent_figures_cnt] => 153
[patent_no_of_words] => 37885
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/947/07947822.pdf
[firstpage_image] =>[orig_patent_app_number] => 12683844
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/683844 | HIV vaccines based on Env of multiple clades of HIV | Jan 6, 2010 | Issued |
Array
(
[id] => 6411874
[patent_doc_number] => 20100166709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Novel Bacteriophage and Antibacterial Composition Comprising the Same'
[patent_app_type] => utility
[patent_app_number] => 12/645414
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11784
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20100166709.pdf
[firstpage_image] =>[orig_patent_app_number] => 12645414
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/645414 | Novel Bacteriophage and Antibacterial Composition Comprising the Same | Dec 21, 2009 | Abandoned |
Array
(
[id] => 6597467
[patent_doc_number] => 20100292181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/639751
[patent_app_country] => US
[patent_app_date] => 2009-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13286
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292181.pdf
[firstpage_image] =>[orig_patent_app_number] => 12639751
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/639751 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTIONS | Dec 15, 2009 | Abandoned |
Array
(
[id] => 8066261
[patent_doc_number] => 20110243896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'ANTI-VIRAL PROTECTION WITH VIRUSES CONTAINING DEFECTIVE GENOME SEGMENTS'
[patent_app_type] => utility
[patent_app_number] => 13/132593
[patent_app_country] => US
[patent_app_date] => 2009-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18373
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20110243896.pdf
[firstpage_image] =>[orig_patent_app_number] => 13132593
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/132593 | Anti-viral protection with viruses containing defective genome segments | Dec 7, 2009 | Issued |
Array
(
[id] => 6014925
[patent_doc_number] => 20110223196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'HIV/SIV VACCINES FOR THE GENERATION OF MUCOSAL AND SYSTEMIC IMMUNITY'
[patent_app_type] => utility
[patent_app_number] => 13/129920
[patent_app_country] => US
[patent_app_date] => 2009-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 28105
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20110223196.pdf
[firstpage_image] =>[orig_patent_app_number] => 13129920
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129920 | HIV/SIV VACCINES FOR THE GENERATION OF MUCOSAL AND SYSTEMIC IMMUNITY | Nov 22, 2009 | Abandoned |
Array
(
[id] => 7742335
[patent_doc_number] => 20120020994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'MULTIVALENT, DRYING RESISTANT, EVOLUTION-BASED VACCINES'
[patent_app_type] => utility
[patent_app_number] => 13/131394
[patent_app_country] => US
[patent_app_date] => 2009-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12650
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20120020994.pdf
[firstpage_image] =>[orig_patent_app_number] => 13131394
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/131394 | MULTIVALENT, DRYING RESISTANT, EVOLUTION-BASED VACCINES | Nov 19, 2009 | Abandoned |
Array
(
[id] => 6575240
[patent_doc_number] => 20100129398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'Materials and Methods for Control of Porcine Reproductive and Respiratory Syndrome'
[patent_app_type] => utility
[patent_app_number] => 12/620495
[patent_app_country] => US
[patent_app_date] => 2009-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 14850
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129398.pdf
[firstpage_image] =>[orig_patent_app_number] => 12620495
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/620495 | Materials and Methods for Control of Porcine Reproductive and Respiratory Syndrome | Nov 16, 2009 | Abandoned |
Array
(
[id] => 6543133
[patent_doc_number] => 20100125053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-20
[patent_title] => 'Allosteric Modulation of the Dopamine Transporter Protein for the Treatment of HIV-1 Induced Neurologic Dysfunction'
[patent_app_type] => utility
[patent_app_number] => 12/620170
[patent_app_country] => US
[patent_app_date] => 2009-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11778
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20100125053.pdf
[firstpage_image] =>[orig_patent_app_number] => 12620170
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/620170 | Allosteric Modulation of the Dopamine Transporter Protein for the Treatment of HIV-1 Induced Neurologic Dysfunction | Nov 16, 2009 | Abandoned |
Array
(
[id] => 6428671
[patent_doc_number] => 20100168402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Direct Attachment of Polypeptides to Virus Like Particles'
[patent_app_type] => utility
[patent_app_number] => 12/619442
[patent_app_country] => US
[patent_app_date] => 2009-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11053
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168402.pdf
[firstpage_image] =>[orig_patent_app_number] => 12619442
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/619442 | Direct Attachment of Polypeptides to Virus Like Particles | Nov 15, 2009 | Abandoned |
Array
(
[id] => 6232044
[patent_doc_number] => 20100184836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'VACCINE'
[patent_app_type] => utility
[patent_app_number] => 12/578969
[patent_app_country] => US
[patent_app_date] => 2009-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 16198
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184836.pdf
[firstpage_image] =>[orig_patent_app_number] => 12578969
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/578969 | VACCINE | Oct 13, 2009 | Abandoned |